[1]
|
Adelugba, I., Siddiqui, S., Aziz, A., et al. (2023) Interstitial Cystitis/Bladder Pain Syndrome: What Today’s Urologist should Know. Current Bladder Dysfunction Reports, 18, 16-28. https://doi.org/10.1007/s11884-022-00676-1
|
[2]
|
Clemens, J.Q., Erickson, D.R., Varela, N.P. and Lai, H.H. (2022) Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Journal of Urology, 208, 34-42. https://doi.org/10.1097/JU.0000000000002756
|
[3]
|
Anger, J.T., Dallas, K.B., Bresee, C., De Hoedt, A.M., Barbour, K.E., Hoggatt, K.J., Goodman, M.T., Kim, J. and Freedland, S.J. (2022) National Prevalence of IC/BPS in Women and Men Utilizing Veterans Health Administration Data. Frontiers in Pain Research, 3, Article 925834. https://doi.org/10.3389/fpain.2022.925834
|
[4]
|
Akiyama, Y., Luo, Y., Hanno, P.M., Maeda, D. and Homma, Y. (2020) Interstitial Cystitis/Bladder Pain Syndrome: The Evolving Landscape, Animal Models and Future Perspectives. International Journal of Urology, 27, 491-503. https://doi.org/10.1111/iju.14229
|
[5]
|
Homma, Y., Akiyama, Y., Tomoe, H., Furuta, A., Ueda, T., Maeda, D., Lin, A.T., Kuo, H.C., Lee, M.H., Oh, S.J., Kim, J.C. and Lee, K.S. (2020) Clinical Guidelines for Interstitial Cystitis/Bladder Pain Syndrome. International Journal of Urology, 27, 578-589. https://doi.org/10.1111/iju.14234
|
[6]
|
Windgassen, S. and McKernan, L. (2020) Cognition, Emotion, and the Bladder: Psychosocial Factors in Bladder Pain Syndrome and Interstitial Cystitis (BPS/IC). Current Bladder Dysfunction Reports, 15, 9-14. https://doi.org/10.1007/s11884-019-00571-2
|
[7]
|
Jabbari, B. (2018) Botulinum Toxin Treatment. Springer International Publishing, Cham. https://doi.org/10.1007/978-3-319-99945-6
|
[8]
|
Jiang, Y.-H., Jhang, J.-F. and Kuo, H.-C. (2022) The Clinical Application of Intravesical Botulinum Toxin A Injection in Patients with Overactive Bladder and Interstitial Cystitis. Tzu Chi Medical Journal, 35, 31-37. https://doi.org/10.4103/tcmj.tcmj_313_21
|
[9]
|
Simpson, L.L. (1980) Kinetic Studies on the Interaction Between Botulinum Toxin Type A and the Cholinergic Neuromuscular Junction. Journal of Pharmacology and Experimental Therapeutics, 212, 16-21.
|
[10]
|
Giannantoni, A., Gubbiotti, M. and Bini, V. (2019) Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis. Toxins, 11, Article 510. https://doi.org/10.3390/toxins11090510
|
[11]
|
Engeler, D., Bananowski, A.P., Berghmans, B., et al. (2019) EAU Guidelines on Chronic Pelvic Pain. European Association of Urology, Arnhem.
|
[12]
|
Yu, W.-R., Jhang, J.-F. and Kuo, H.-C. (2024) Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome. Toxins, 16, Article 74. https://doi.org/10.3390/toxins16020074
|
[13]
|
王伟, 杨建军, 杨关天, 等. 放射性膀胱炎的治疗进展[J]. 临床泌尿外科杂志, 2019, 34(6): 489-492. https://doi.org/10.13201/J.Issn.1001-1420.2019.06.019
|
[14]
|
巫嘉文, 余洋. 高压氧综合治疗出血性放射性膀胱炎56例疗效观察[J]. 中华航海医学与高气压医学杂志, 2016, 23(4): 323-325.
|
[15]
|
Eastman, R., Leaf, E.M., Zhang, D., True, L.D., Sweet, R.M., Seidel, K., Siebert, J.R., Grady, R., Mitchell, M.E. and Bassuk, J.A. (2010) Fibroblast Growth Factor-10 Signals Development of Von Brunn’s Nests in the Exstrophic Bladder. American Journal of Physiology-Renal Physiology, 299, F1094-F1110. https://doi.org/10.1152/ajprenal.00056.2010
|
[16]
|
Xin, Z., Zhao, C., Huang, T., Zhang, Z., Chu, C., Lu, C., Wu, M. and Zhou, W. (2016) Intestinal Metaplasia of the Bladder in 89 Patients: A Study with Emphasis on Long-Term Outcome. BMC Urology, 16, Article No. 24. https://doi.org/10.1186/s12894-016-0142-x
|
[17]
|
Li, R. and Leslie, S.W. (2023) Cystitis. StatPearls Publishing, Treasure Island.
|
[18]
|
Reddy, M. and Zimmern, P.E. (2022) Efficacy of Antimicrobial Intravesical Treatment for Uncomplicated Recurrent Urinary Tract Infections: A Systematic Review. International Urogynecology Journal, 33, 1125-1143. https://doi.org/10.1007/s00192-021-05042-z
|
[19]
|
Sabih, A. and Leslie, S.W. (2023) Complicated Urinary Tract Infections. StatPearls Publishing, Treasure Island.
|
[20]
|
Chiu, K., Zhang, F., Sutcliffe, S., Mysorekar, I.U. and Lowder, J.L. (2022) Recurrent Urinary Tract Infection Incidence Rates Decrease in Women with Cystitis Cystica after Treatment with D-Mannose: A Cohort Study. Female Pelvic Medicine & Reconstructive Surgery, 28, e62-e65. https://doi.org/10.1097/SPV.0000000000001144
|
[21]
|
De Nunzio, C., Bartoletti, R., Tubaro, A., Simonato, A. and Ficarra, V. (2021) Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives. Antibiotics, 10, Article 373. https://doi.org/10.3390/antibiotics10040373
|
[22]
|
Yuksel, O.H., Urkmez, A., Erdogru, T. and Verit, A. (2015) The Role of Steroid Treatment in Intractable Cystitis Glandularis: A Case Report and Literature Review. Canadian Urological Association Journal, 9, E306-E309. https://doi.org/10.5489/cuaj.2636
|
[23]
|
Koyama, J., Namiki, S., Kudo, T., Aizawa, M., Ioritani, N. and Nakamura, Y. (2019) Typical Type Cystitis Glandularis Presenting Urinary Retention in a Young Man: Adjuvant Therapy Using Oral Cyclooxygenase-2 Inhibitor: A Case Report. Nihon Hinyokika Gakkai Zasshi, 110, 148-151. (In Japanese) https://doi.org/10.5980/jpnjurol.110.148
|
[24]
|
Ni, Y., Zhao, S., Yin, X., Wang, H., Guang, Q., Hu, G., Yang, Y., Jiao, S. and Shi, B. (2017) Intravesicular Administration of Sodium Hyaluronate Ameliorates the Inflammation and Cell Proliferation of Cystitis Cystica et Glandularis Involving Interleukin-6/JAK2/Stat3 Signaling Pathway. Scientific Reports, 7, Article No.15892. https://doi.org/10.1038/s41598-017-16088-9
|
[25]
|
Ballas, K., Rafailidis, S., Pavlidis, T., Marakis, G., Psarras, K., Anagnostara, E. and Sakadamis, A. (2007) Gangrenous Cystitis. International Urogynecology Journal, 18, 1507-1509. https://doi.org/10.1007/s00192-007-0430-9
|
[26]
|
Elalaoui, A., Elmoudane, A., Mokhtari, M., Elfarhaoui, H., Motaouakil, A. and Barki, A. (2022) Rare Case of Gangrenous Cystitis Revealed by Acute Peritonitis. Urology Case Reports, 45, Article 102239. https://doi.org/10.1016/j.eucr.2022.102239
|
[27]
|
Kotoulas, K., Georgellis, C., Kigitzi, E., Liappis, A., Spounos, M., Tsalkidou, V. and Patris, E. (2018) Acute Diffuse Peritonitis Caused by Urinary Retention: A Rare Case of Gangrenous Cystitis. Case Reports in Urology, 2018, Article ID: 4948375. https://doi.org/10.1155/2018/4948375
|
[28]
|
Fujiwara, S., Noguchi, T., Noguchi, T., Emoto, A. and Tasaki, Y. (2008) Panperitonitis Caused by Gangrene of the Urinary Bladder: Report of a Successfully Treated Case. The American Surgeon, 74, 302-304. https://doi.org/10.1177/000313480807400404
|
[29]
|
White, M.D., Das, A.K. and Kaufman, R.P. (1998) Gangrenous Cystitis in the Elderly: Pathogenesis and Management Options. British Journal of Urology, 82, 297-299. https://doi.org/10.1046/j.1464-410X.1998.00741.x
|
[30]
|
Thomas, A.A., Lane, B.R., Thomas, A.Z., Remer, E.M., Campbell, S.C. and Shoskes, D.A. (2007) Emphysematous Cystitis: A Review of 135 Cases. BJU International, 100, 17-20. https://doi.org/10.1111/j.1464-410X.2007.06930.x
|
[31]
|
Amano, M. and Shimizu, T. (2014) Emphysematous Cystitis: A Review of the Literature. Internal Medicine, 53, 79-82. https://doi.org/10.2169/internalmedicine.53.1121
|
[32]
|
Huang, J.-J., Chen, K.-W. and Ruaan, M.-K. (1991) Mixed Acid Fermentation of Glucose as a Mechanism of Emphysematous Urinary Tract Infection. Journal of Urology, 146, 148-151. https://doi.org/10.1016/S0022-5347(17)37736-4
|
[33]
|
Hudnall, M.T., Jordan, B.J., Horowitz, J. and Kielb, S. (2019) A Case of Emphysematous Cystitis and Bladder Rupture. Urology Case Reports, 24, Article 100860. https://doi.org/10.1016/j.eucr.2019.100860
|
[34]
|
Murata, Y., Matsuo, Y. and Hiraoka, E. (2023) Successful Conservative Management of Emphysematous Cystitis with Pneumoperitoneum: A Case Report and Literature Review. Cureus, 15, e43769. https://doi.org/10.7759/cureus.43769
|
[35]
|
李小青, 朱燃培, 张华, 等. 清心莲子饮加减治疗放射性膀胱炎经验探析[J]. 中华中医药杂志, 2024, 39(2): 818-821.
|